Small Business Innovation Research (SBIR) Program and Small Business Technology Transfer (STTR) Program (Child Psychopathology)

Overview

The Small Business Innovation Research Program supports research and development by small businesses of innovative technologies that have the potential to succeed commercially or provide significant societal benefits. The Small Business Technology Transfer Program has the same objectives, but requires academic research involvement. In DTR the SBIR and STTR programs support research aimed at the development and validation of new methods and techniques to advance understanding, prevention, and treatment of child psychopathology.

Areas of Emphasis

• Development of novel pharmacologic or behavioral interventions for the treatment of child psychopathology.
• Use of biomedical computation to advance and test new models of child psychopathology.
• Development of biomarkers to assess pediatric mental function and dysfunction as related to mental illness.
• Development of novel diagnostic tools and innovative measures of treatment response and disease progression, preclinical or clinical efficacy testing, or toxicity measures for drug development.
• Development of hardware and software tools to enable refined physiological and behavioral assessment of normal and atypical infant and child development.
• Web-based tools to enhance prevention, early identification and treatment of pediatric mental disorders by various educational and health professionals.
• Development of hardware and software tools to support operations of multi-site clinical trials.

Contact

Margaret C. Grabb, Ph.D.
Program Chief
6001 Executive Boulevard, Room 7203, MSC 9645
301-443-3563, mgrabb@mail.nih.gov